FDA's Opioids Adviser Accuses Agency Of Having 'Direct' Link To Crisis

In an exclusive, Chris McGreal, writing in The Guardian, reveals that the head of the US Food and Drug Administration’s opioid advisory team says officials are manipulating process to benefit big pharma.